Target intelligence / Profile preview

ANKRD11 pseudogene 2 (ANKRD11P2)

Target
ANKRD11P2
Molecular classification
Other, pseudogene
01

Overview

ANKRD11 pseudogene 2 (ANKRD11P2) refers to a non-functional genomic sequence with high homology to the ankyrin repeat domain 11 gene (ANKRD11). Related pseudogenes exist on chromosomes 2 and X, but do not encode an active protein, nor do they have recognized biological or therapeutic roles[3][5]. The protein-coding homolog (ANKRD11) is a chromatin regulator involved in transcription, neural and skeletal development, and is linked to KBG syndrome and other neurodevelopmental disorders[1][2][4][5][6]. However, ANKRD11P2 lacks direct evidence of expression, function, or disease association in the available scientific literature. Critical Notes: - ANKRD11 (not ANKRD11P2) is a well-characterized protein-coding gene and is a therapeutic or research target; all disease, molecular, and functional associations are specific to it[1][2][3][4][5][6][7]. ANKRD11P2 is a pseudogene and does not serve as a therapeutic target, does not have direct biological function, and is not part of major molecular families. - ANKRD11P2 is not a receptor, enzyme, transporter, transcription factor, nor any functional molecule. It is incorrectly presented as a target for therapeutic or research purposes. If you require structured information about the biologically active protein-coding gene, refer to Ankyrin repeat domain containing 11 (ANKRD11) instead.

Beyond the preview

Go deeper on ANKRD11 pseudogene 2 (ANKRD11P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD11 pseudogene 2 (ANKRD11P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call